Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTCY NASDAQ:NMTC NASDAQ:PYPD NASDAQ:QTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$0.38+4.2%$0.47$0.19▼$1.01$9.34M1.1136,729 shs25,241 shsNMTCNeuroOne Medical Technologies$0.74+1.1%$0.64$0.40▼$1.39$36.81M0.66187,350 shs168,963 shsPYPDPolyPid$3.43-0.6%$3.11$2.30▼$4.42$34.95M1.32133,286 shs113,379 shsQTIQT Imaging$1.85+30.3%$0.88$0.35▼$0.84$50.12M-0.2171,840 shs190,819 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity-14.28%-2.75%-31.41%-5.24%-52.96%NMTCNeuroOne Medical Technologies+2.24%+7.77%+25.67%+66.14%-9.12%PYPDPolyPid-1.15%-2.27%+5.50%+40.59%-13.75%QTIQT Imaging0.00%+2.01%+79.49%+170.10%+99.52%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTCYBiotricityN/AN/AN/AN/AN/AN/AN/AN/ANMTCNeuroOne Medical Technologies2.2139 of 5 stars3.55.00.00.00.60.80.0PYPDPolyPid2.1034 of 5 stars3.63.00.00.01.11.70.0QTIQT ImagingN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTCYBiotricity 2.00HoldN/AN/ANMTCNeuroOne Medical Technologies 3.00Buy$1.4596.24% UpsidePYPDPolyPid 3.17Buy$11.80244.02% UpsideQTIQT Imaging 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BTCY, QTI, PYPD, and NMTC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/18/2025PYPDPolyPidRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$12.00 ➝ $9.006/17/2025PYPDPolyPidJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Outperform ➝ Market Outperform$16.00 ➝ $14.006/9/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$11.00 ➝ $13.006/5/2025PYPDPolyPidRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$9.006/2/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeBuy$11.005/5/2025NMTCNeuroOne Medical TechnologiesLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.454/14/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$11.00 ➝ $11.00(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTCYBiotricity$12.06M0.77N/AN/A($1.30) per share-0.29NMTCNeuroOne Medical Technologies$3.45M10.67N/AN/A$0.03 per share24.63PYPDPolyPidN/AN/AN/AN/A$0.75 per shareN/AQTIQT Imaging$4.00M12.54N/AN/A($1.91) per share-0.97Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTCYBiotricity-$14.09M-$1.08N/A∞N/A-80.42%N/A-188.47%8/18/2025 (Estimated)NMTCNeuroOne Medical Technologies-$12.32M-$0.22N/A∞N/A-75.41%-334.64%-124.42%8/13/2025 (Estimated)PYPDPolyPid-$29.02M-$4.30N/A∞N/AN/A-1,069.37%-151.85%8/13/2025 (Estimated)QTIQT Imaging-$4.03MN/A0.00∞N/AN/AN/A-65.94%8/6/2025 (Estimated)Latest BTCY, QTI, PYPD, and NMTC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025PYPDPolyPid-$0.80-$0.70+$0.10-$0.70N/AN/A5/13/2025Q2 2025NMTCNeuroOne Medical Technologies-$0.09-$0.07+$0.02-$0.07$1.27 billion$1.39 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTCYBiotricityN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/APYPDPolyPidN/AN/AN/AN/AN/AQTIQT ImagingN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTCYBiotricityN/A0.230.10NMTCNeuroOne Medical TechnologiesN/A2.131.09PYPDPolyPid4.430.710.71QTIQT ImagingN/A1.060.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTCYBiotricity3.89%NMTCNeuroOne Medical Technologies16.07%PYPDPolyPid26.47%QTIQT Imaging24.19%Insider OwnershipCompanyInsider OwnershipBTCYBiotricity10.10%NMTCNeuroOne Medical Technologies8.90%PYPDPolyPid24.70%QTIQT Imaging75.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTCYBiotricity4024.91 million22.08 millionOptionableNMTCNeuroOne Medical Technologies2049.82 million45.38 millionOptionablePYPDPolyPid8010.19 million7.67 millionNo DataQTIQT ImagingN/A27.13 million6.68 millionN/ABTCY, QTI, PYPD, and NMTC HeadlinesRecent News About These CompaniesQT Imaging Bolsters Medical and Clinical Leadership with Senior Appointments to Further Drive Innovation and Clinical AdoptionJuly 8 at 10:20 AM | finance.yahoo.comQT Imaging to Hold Virtual 2025 Annual Meeting of Stockholders on August 19July 3, 2025 | businesswire.comQT Imaging Leverages NVIDIA L40 GPU Acceleration to Power its Next-Gen Breast Imaging Reconstruction SoftwareJune 25, 2025 | tmcnet.comLadenburg Thalmann Initiates Coverage of QT Imaging Holdings (QTIH) with Buy RecommendationMay 20, 2025 | msn.comQT Imaging Holdings Delivers Its Breast Imaging Scanner to Innovative Radiology in Des Moines, IowaMay 15, 2025 | finance.yahoo.comQT Imaging Holdings Announces $200,000 PIPE InvestmentMay 14, 2025 | joplinglobe.comJQT Imaging Announces First Quarter 2025 Financial ResultsMay 13, 2025 | businesswire.comQT Imaging Approves Executive Stock Options PlanApril 23, 2025 | tipranks.comQT Imaging Holdings Announces $500,000 Insiders PIPE InvestmentApril 10, 2025 | businesswire.comQT Imaging Holdings Announces $500,000 Insiders PIPE InvestmentApril 10, 2025 | businesswire.comQT Imaging Holdings to Participate in the 2025 SBI Breast Imaging SymposiumApril 8, 2025 | businesswire.comQT Imaging Announces Fourth Quarter and Full Year 2024 Financial Results and Provides 2025/26 OutlookApril 2, 2025 | seekingalpha.comQT Imaging Holdings Announces Shipment of Six QT Breast Acoustic CT Scanners in the First Quarter of 2025April 1, 2025 | businesswire.comQT Imaging Holdings Receives $10.1 Million in New Funding to Support Working Capital and Retire DebtFebruary 27, 2025 | businesswire.comQTI Stock Earnings: QT Imaging Holdings Reported Results for Q2 2024February 14, 2025 | investorplace.comQT Imaging Holdings Inc. secures sublease agreementJanuary 24, 2025 | msn.comQT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan TimeJanuary 15, 2025 | joplinglobe.comJQT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue GrowthJanuary 13, 2025 | finance.yahoo.comQT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri CenterDecember 12, 2024 | finance.yahoo.comQT Imaging Holdings to Attend Radiological Society of North America 2024 Annual MeetingNovember 21, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBTCY, QTI, PYPD, and NMTC Company DescriptionsBiotricity NASDAQ:BTCY$0.38 +0.02 (+4.17%) As of 03:45 PM EasternBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.NeuroOne Medical Technologies NASDAQ:NMTC$0.74 +0.01 (+1.08%) Closing price 04:00 PM EasternExtended Trading$0.74 +0.00 (+0.01%) As of 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.PolyPid NASDAQ:PYPD$3.43 -0.02 (-0.58%) Closing price 04:00 PM EasternExtended Trading$3.44 +0.00 (+0.15%) As of 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.QT Imaging NASDAQ:QTI$1.85 +0.43 (+30.25%) As of 07/7/2025QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Sizzling Insider Buys for Your High-Yield Watchlist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
